For the most common form of childhood eye cancer, unilateral retinoblastoma, shortening the time from the first appearance of symptoms to diagnosis of disease has no bearing on survival or stage of the disease, according to a study by researchers at Co…
Author: The Medical News
Eye abnormalities may help reveal features of early-stage Alzheimer’s disease, says study
Investigators at the Cedars-Sinai Regenerative Medicine Institute have discovered eye abnormalities that may help reveal features of early-stage Alzheimer’s disease. Using a novel laboratory rat model of Alzheimer’s disease and high-resolution imaging techniques, researchers correlated variations of the eye structure, to identify initial indicators of the disease.
Building muscle mass important in decreasing metabolic risk
New UCLA research suggests that the more muscle mass older Americans have, the less likely they are to die prematurely. The findings add to the growing evidence that overall body composition – and not the widely used body mass index, or BMI – is a bett…
Researchers develop new software to aid cardiovascular risk diagnosis based on fundus image processing
Researchers from the Universitat Politècnica de València, the Hospital General de Valencia and the Ophthalmology Unit of the Foundation for the Health and Biomedical Research of the Comunitat Valenciana (FISABIO-Oftalmología Médica) have developed a new software to aid cardiovascular risk diagnosis based on fundus image processing.
Driving simulator may help people with hemianopia to drive safely
A diagnosis of hemianopia, or blindness in one half of the visual field in both eyes as the result of strokes, tumors or trauma often means the end of driving.
PowerVision develops world’s first fluid-based accommodating intraocular lens
PowerVision, Inc., a medical device company developing the world’s first fluid-based accommodating intraocular lens, today announced that the first 10 patients have received lens implants in its multi-center clinical study assessing the performance of …
Eye health experts across Commonwealth join forces to combat avoidable blindness
A new -7.1 million grant will enable experts from a range of institutions to come together for the first time as the Commonwealth Eye Health Consortium, coordinated by the International Centre for Eye Health at the London School of Hygiene & Tropical Medicine.
Cataract surgery followed by use of contact lenses may be better solution for infants
For adults and children who undergo cataract surgery, implantation of an artificial lens is the standard of care. But a clinical trial suggests that for most infants, surgery followed by the use of contact lenses for several years—and an eventual lens implant—may be the better solution.
Ohr Pharmaceutical partners with CSHL to develop trodusquemine and related analogs
Ohr Pharmaceutical, a pharmaceutical company focused on the development of novel therapeutics for large unmet medical needs, and leading global cancer research center Cold Spring Harbor Laboratory (CSHL) today announced the establishment of DepYmed Inc…
Study establishes innovative approaches to improve vision of young children with brain tumor
Robert Avery, DO, MSCE, of Children’s National Health System and colleagues are establishing innovative approaches with technology and medication to improve the vision of young children who have visual pathway glioma, a type of brain tumor.
Abingworth announces final closing of £225M ($375M) fund
Abingworth, the international investment group dedicated to life sciences and healthcare, today announced the final closing of its £225m ($375m) fund, Abingworth Bioventures VI (ABV VI). ABV VI, Abingworth’s 10th life sciences fund, exceeded its target of £200 million and invests in life sciences and healthcare both in Europe and the US.
New corneal layer important for intraocular pressure maintenance
UK researchers have found that a newly discovered layer of the human eye is an important part of the structural tissue that helps to maintain intraocular pressure and thus may play a role in the development of glaucoma.
UAB launches pilot program to detect earlier stages of glaucoma
Glaucoma is a silent disease. It does not hurt, symptoms are slow to develop, and most people do not notice any loss of vision until it is too late. A project by ophthalmologists at the University of Alabama at Birmingham will examine whether a partner…
Jackson Laboratory Assistant Professor wins 2013 Lewis Rudin Glaucoma Prize from NYAM
Jackson Laboratory Assistant Professor Gareth Howell, Ph.D., is one of two winners of the 2013 Lewis Rudin Glaucoma Prize from The New York Academy of Medicine.
Research roundup: Palliative care And acos; employers and Supreme Court case on contraception
In preparation for the new ACO environment, leaders recognized the contribution palliative care can make to health care “value,” especially in the care of our sickest (and most expensive) patients …
Study indicates relationship between multivitamin supplement use and cataract risk in men
Long-term daily multivitamin supplement use may lower cataract risk in men, according to a study of nearly 15,000 male physicians published this month in Ophthalmology, the journal of the American Academy of Ophthalmology
UPV/EHU researchers develop method for diagnosis, prognosis of cutaneous melanoma
UPV/EHU researchers have developed a method for the diagnosis and prognosis of cutaneous melanoma, the type of skin cancer with the highest mortality rate.This method will help not only in the more effective early detection of this cancer, but also in the development of more personalised treatments.
Duke University Eye Center ophthalmologist uses ReSure Sealant to perform first cataract surgeries
Terry Kim, MD, Professor of Ophthalmology at Duke University Eye Center, performed the first procedures using the ReSure Sealant on his cataract patients in Durham, North Carolina. The ReSure Sealant is the first FDA-approved sealant for ophthalmic use…
Dua’s Layer in the human cornea may be linked to glaucoma
A new layer in the human cornea – discovered by researchers at The University of Nottingham last year – plays a vital role in the structure of the tissue that controls the flow of fluid from the eye, research has shown.
Aerpio Therapeutics doses first patient in AKB-9778 Phase 2 trial for diabetic macular edema treatment
Aerpio Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases, today announced that it has dosed the first patient in a Phase 2 trial evaluating AKB-9778, a Tie2 activator, alone and in combination with ranibizumab (Lucentis) for the treatment of diabetic macular edema (DME). AKB-9778 is a first-in-class inhibitor of human protein tyrosine phosphatase beta (HPTPβ) that activates the Tie2 pathway to promote vascular stability, preventing abnormal blood vessel growth and vascular leak.